Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Direvo Validates BluZy™ Technology in Collaboration with US CCUR

Published: Friday, December 21, 2012
Last Updated: Friday, December 21, 2012
Bookmark and Share
Company has successfully completed the scale up of BluZy™-D and BluZy™-P.

Direvo Industrial Biotechnology GmbH has successfully completed the scale up of its first two products BluZy™-D and BluZy™-P in collaboration with the Center for Crops Utilization Research (CCUR) and the BioCentury Research Farm (BCRF) at Iowa State University.

A team led by Dr. Larry Johnson, director of CCUR and BCRF, conducted lab-scale and pilot-scale trials to test the effects of the enzyme technology on ethanol production and processed samples of enzyme-modified DDGS and unmodified DDGS for analytical and nutritional comparison purposes.

From this work, Direvo validated the performance of BluZy™-D that substantially improved nutritional value as compared to commercially available DDGS.

The production was further scaled up at BCRF where more than one ton of DDGS was produced for further evaluation in broiler feeding trials at major universities in the US.

BluZy™-P the second product of Direvo´s BluZy™ product development platform was also evaluated by the experts at BCRF. BluZy™-P improved process efficiency of ethanol production at multiple steps and significantly simplified back end oil separation.

“The pilot-scale facilities for dry-grind ethanol production at BCRF offered Direvo the ideal opportunity to test this new and unique technology prior to full-scale production,” said Klaudija Milos, Vice President Business Unit Industrial Solutions.

Milos continued, “Our recent project results demonstrate the validity of our technologies and the economic benefit for two large industries in the US, ethanol and animal production.”

Direvo will be exploring various industry opportunities as it proceeds in scaling up the BluZy™-Technology for commercial operations.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

European and US Cellulase Patents Granted to Direvo
Granted patents describe improved cellulase enzymes having CBH II activity.
Wednesday, May 22, 2013
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Researchers Develop Software That Could Facilitate Drug Development
AptaTRACE can identify aptamers, potentially speed drug advancement.
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Zika Vaccine Candidates Show Promise
Two experimental vaccines have shown promise against a major viral strain responsible for the Brazilian Zika outbreak.
New Medication Shows Promise Against Liver Fibrosis in Animal Studies
Liver fibrosis is a gradual scarring of the liver that puts people at risk for progressive liver disease and liver failure.
Raw Eggs Deemed Safe to Eat
A report published today by the Advisory Committee on the Microbiological Safety of Food (ACMSF) into egg safety has shown a major reduction in the risk from salmonella in UK eggs.
Monitoring TTX Toxin in Shellfish
In a number of small studies, mussels and oysters from the eastern and northern part of the Oosterschelde in Holland were found to contain tetrodotoxin (TTX).
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!